NASDAQ · OACCU
Financial Services · Asset Management
$11.00
Down-$0.03 (-0.27%)
Updated Aug 26, 2026, 1:45 PM
SID Score
3.8/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 1 trading sessions · Daily adjusted prices
OACCU closed at $11.00 after 1 trading sessions, up 0.00% for the selected period.
No results
At least two price observations are needed to draw this chart.
The latest Smart Investors Daily articles mentioning OACCU.
OACCU research
Company profile and research snapshot.
Oaktree Acquisition Corp III Life Sciences is a blank check company.
Visit company websiteConsensus and target data currently published for this company.
No generated briefing is available yet.
GlobeNewswire Inc. · Apr 15, 2025
Verona Pharma reported strong financial results for Q4 and 2024, with its product Ohtuvayre (ensifentrine) recording net sales of $36.6 million in Q4 and $42.3 million in 2024. The company also announced an amended strategic financing with Oaktree and OMERS, including a term loan facility increase and access to additional funding.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning OACCU.
No results
No recent SID articles mention OACCU.
